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(Spp1) in microglia-activating fractions. Both osteopontin and lac-
tadherin are avb3/avb5 integrin ligands able to interact with
receptors present on microglia and macrophages and thus could
be involved in pro-invasive polarization of microglia/
macrophages. Moreover, both Spp1 and Mfge8 are overexpressed
in glioma cells, but not in non-transformed astrocytes. C6 glioma
cells stably expressing shRNA specific to lactadherin (shMfge8),
osteopontin (shSpp1) and negative shRNA (shNeg) were
implanted into striatum of Wistar rats. There was no difference
in proliferation and viability of C6 glioma cells, cells stably
expressing shRNA specific to lactadherin, ostopontin and nega-
tive shRNA in vitro, that demonstrates the negligible effect of
autocrine production of both protein on tumor cell growth.
Knockdown of Spp1 and Mfge8 resulted in significant reduction
of tumor volume in rat model of glioma. Immunochemical anal-
ysis of brain sections revealed similar numbers of infiltrating
microglia/macrophages (Iba1 staining), but the reduced number
of ameboid, arginase 1 expressing cells in Mfge8 – depleted tumor.
Treatment of endothelial cells with rhMFGE8 revealed significant
effect of that protein on angiogenesis in vitro, however
lactadherin-depleted tumors do not exhibit reduced blood vessel
density in rat glioma model. FACS analysis showed that silencing
of Spp1 does not affect total number of CD11b-positive cells, but
strongly modulates microenvironment by leading to significant
changes in percentage of Tc and Treg cells infiltrating tumor-
bearing hemisphere. Our results suggest that glioma-derived
integrin ligands are important factor in polarization of glioma
infiltrating microglia/macrophages into the pro-invasive pheno-
type and its targeting could be a new therapeutic strategy.
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It’s well documented that cytokines in patients with breast
cancer are indicators of survival, assessing the risk of recurrence
and mortality. However, the obtained data about serum levels of
cytokines are contradictory. The problem of participation of
cytokines in the growth and spread of tumors requires further
study.
The purpose was the determination of serum level of cytokine
in experimental model of breast cancer in Wistar rat. Material
and methods: Breast cancer was induced by intramammalirian
injection of N-methyl-N-nitrosourea. Some of the rats were sub-
jected to only surgery or only polychemotherapy (cyclophos-
phamide, methotrexate, 5-fluorouracil).Serum levels of
cytokines: Bio-Plex Pro Rat Cytokines 24-Plex Assay (Bio-Rad,
USA) were used.
Results: It was found that the serum levels of IL-1b, IL-2, IL-4,
IL-5, IL-6, IL-7, IL-12, IL-13, IL-17A, IFN -c, MIP-1a, MIP-3a, RANTES,
TNF-a in rats with experimental breast cancer were significantly
higher compared with intact rats. We obtained that pro-
inflammatory cytokines are associated with progression of breast
cancer in rats. The serum levels of IL-1a, IL-2, IL-4, IL-12, IL-18,
G-CSF, GM-CSF, GRO/KC, IFN-c, MIP-1a, RANTES in rats after
surgical treatment were significantly higher compared to those
in rats without surgical treatment. It was also observed that in
rats after surgical treatment,the serum levels of IL-1a, IL-2, IL-4,
IL-12, IL-18, G-CSF, GM-CSF, GRO/KC, IFN-c, MIP-1a, RANTES were
decreased. We suppose that these data may indicate that tumor
cells can also produce cytokines. Moreover, we obtained that in
intact rats, serum levels of IL-1a, IL-18, EPO, G-CSF, GRO/KC,
MIP-1a were higher compared to those in rats with breast
cancer treated with surgery. However, the serum levels of IL-6
and IL-1b (markers of pro- inflammation and tumor metastasis)
were higher in surgically treated rats compared to those in intact
rats. It has been proved that the removal of primary tumors
(without regional lymph node removal and subsequent poly-
chemotherapy) can lead to accelerated growth of metastases. It
was found that the polychemotherapy resulted in a significant
decrease in the serum levels of IL-1a, IL-1b, IL-2, IL-4, IL-5, IL-6,
IL-7, IL-10, IL-12, IL-13, IL-17A, IL-18. Polychemotherapy also leads
to suppression in serum levels RANTES, VEGF, MCP-1. We found
that the serum levels of IL-2, IL-5, IL-7, IL-13, IL-17A, IL-18,
G-CSF were significantly higher in rats after combination of
surgery and polychemotherapy.
Conclusion: The serum level of cytokines in rats with experi-
mental breast cancer depends on the type of treatment.
http://dx.doi.org/10.1016/j.ejcsup.2015.08.082
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Colon adenocarcinoma is one of the most wide spreading
malignant tumors in the world, mortality of which remains high.
Estimation of cancer on late stages, absence of prognostic and
predictive factors, poor understanding of progression mechanism
may lead to elevation of mortality.
The aim of investigation was to identify morphologic prognos-
tic factors and their combination for colon adenocarcinoma.
For this purpose 776 patients with colon adenocarcinoma with
the median age 57.6 years were selected. Receptors for chemokine
(CCR10, CXCR4), stem cell marker (ALDH1), ki-67, MSH2, MSH6,
MLH1, PMS2 were investigated by immunohistochemistry (IHC).
Results of IHC were compared with clinical data. Analysis of 217
colon adenocarcinomas by Ki-67 showed that 86% of cases had
high proliferative level (Ki-67>30%), among them 39% of cases
had very high level of Ki-67 (>70%). We also analyzed proliferation
of stem cells using double IHC stain for ALDH1 and Ki-67. It was
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